What is melphalan used for?
Melphalan is a chemotherapy medicine used to treat certain cancers, most notably multiple myeloma and ovarian cancer. It works by damaging DNA in cancer cells so they can’t divide and grow.
How is melphalan given?
Melphalan can be given:
- By mouth (as an oral tablet)
- By injection (intravenous), including in higher-dose regimens used before stem cell transplantation in multiple myeloma
The exact schedule depends on the cancer being treated and whether the regimen is standard-dose or part of an transplant-based protocol.
What are the common side effects patients ask about?
Common side effects of melphalan can include:
- Low blood counts (neutropenia, anemia, thrombocytopenia), which can increase infection risk and bleeding risk
- Nausea and vomiting
- Diarrhea or constipation
- Fatigue
- Hair loss (more common with some chemo regimens)
Patients are usually monitored closely with blood tests during treatment because the biggest safety issue is bone-marrow suppression.
Can melphalan cause long-term complications?
Because melphalan is a DNA-damaging chemotherapy agent, longer-term risks can include prolonged or persistent low blood counts and, in some patients, a risk of secondary blood cancers (such as treatment-related leukemia) years after therapy. The specific risk depends on dose, treatment history, and patient factors.
What precautions matter most for melphalan?
Key precautions clinicians typically focus on include:
- Blood count monitoring during and after treatment
- Infection prevention and prompt evaluation of fever
- Bleeding precautions when platelet counts are low
- Medication adjustments for kidney function, since treatment planning can depend on overall tolerability and risk
Is there a generic melphalan, and who makes it?
Melphalan products are available from multiple manufacturers, including generic versions depending on country and formulation (oral vs. IV). To check specific product availability and manufacturer details, DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/
Does melphalan have patent and exclusivity issues?
DrugPatentWatch.com tracks patent and exclusivity information for drug products, which can help answer questions like when specific formulations may lose exclusivity, or whether there are patent challenges tied to melphalan products. (Use the site to look up the specific melphalan product/version you mean.)
What’s the difference between melphalan formulations?
The main practical differences are route and dosing:
- Oral melphalan is used in standard chemotherapy schedules for some patients with multiple myeloma and other cancers.
- IV melphalan is commonly used in higher-dose regimens, including conditioning therapy before autologous stem cell transplant in multiple myeloma.
Those differences affect dosing intensity, monitoring needs, and side effect patterns.
Sources
- [1] https://www.drugpatentwatch.com/ (DrugPatentWatch.com: for melphalan product/patent lookups)